Contract Services Methods Development
Locus Cell And Charles River Sign Strategic MoU To Advance Cell And Gene Therapy Manufacturing In APAC
Locus Cell Co., Ltd. ("Locus Cell"), a Taiwan-based cell and gene therapy (CGT) Contract Development and Manufacturing Organization (CDMO), and Charles Riv...
March 13, 2026 | News
Sartorius Introduces Genetically Engineered CHO Host Cell Line To Boost Biomanufacturing Productivity
New genetically engineered CHO host cell line strengthens manufacturing efficiency Delivers up to two-fold higher protein expression, three-fold...
March 06, 2026 | News
AtomVie Supplies First Patient Dose In Radiopharm Theranostics Phase 1 2a Study Of 177Lu BetaBart
AtomVie Global Radiopharma (AtomVie), a global leading radiopharmaceutical CDMO, announced that it has supplied the successful dosing of the first pat...
February 26, 2026 | News
Catalent And S Biomedics Partner To Advance Stem Cell Therapy For Parkinsons Disease
Catalent and S.Biomedics announced a strategic partnership to support the development and manufacturing of TED‑A9, S.Biomedics’ allogeneic pluripot...
February 23, 2026 | News
Bon Natural Life Establishes Joint Laboratory To Advance Bio Manufactured Natural Ingredients
Bon Natural Life Limited (Nasdaq: BON) ("BON"or the "Company"), a leading bio-ingredient provider for the natural health and personal care industries, anno...
February 19, 2026 | News
GCCL And Medicover Integrated Clinical Services Sign MOU To Strengthen Multinational Trial Delivery
GCCL Co., Ltd. (GCCL), a data-driven clinical trial services provider, and Medicover Integrated Clinical Services (MICS), part of Medicover, an internation...
February 12, 2026 | News
AsymBio Builds Integrated End To End Platforms To Accelerate Biopharmaceutical Development
AsymBio, a subsidiary of Asymchem Group (stock code: 002821.SZ / 6821.HK), announced that it has established integrated technology platforms span...
February 12, 2026 | News
Made Scientific And Streamline Bio Launch Exclusive AI Driven Early Adopter Programme For GMP Ready Cell Therapy Manufacturing
Made Scientific, a leading clinical- and commercial-enabling cell therapy contract development and manufacturing organization (CDMO), and Streamline Bio, I...
February 12, 2026 | News
WuXi Biologics Partners With Vertex To Advance Trispecific T Cell Engager For Autoimmune Diseases
WuXi Biologics (2269. HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced that it has signed a license ...
February 04, 2026 | News
Ascletis Pharma Reports Positive Phase III Safety Results For Denifanstat In Moderate To Severe Acne
Denifanstat (ASC40), a once-daily oral fatty acid synthase (FASN) inhibitor, demonstrated favorable safety and tolerability in a Phase III open-label ...
February 03, 2026 | News
AstraZeneca Commits $15 Billion Investment To Expand R&D And Manufacturing Footprint In China Through 2030
Landmark investment will expand AstraZeneca’s capabilities to discover, develop, and manufacture transformative new treatments in China In...
February 03, 2026 | News
Merck Strengthens India As A Strategic Healthcare R&D Growth Engine With New Innovation Hub
A workplace designed for long-term growth, efficiency, and innovation Elevating Merck Healthcare’s R&D India Hub as a premier talent powerho...
February 02, 2026 | News
Fidēs Launches Science Led Imaging CRO Focused On Early Phase Clinical Decision Making
Fidēs announced its launch as a new imaging contract research organization (iCRO) designed specifically for early-phase clinical development, where imagin...
February 02, 2026 | News
Samsung Biologics Earns EcoVadis Platinum Sustainability Rating
Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), announced that it has received the EcoVadis...
January 30, 2026 | News
Most Read
- How Does GLP-1 Work?
- Innovations In Magnetic Resonance Imaging Introduced By United Imaging
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
